CXCL12 and chronic myelogenous leukemia, BCR-ABL1 positive: Likewise, altered cytokine expression such as a decrease of CXCL12 production in the BM of a mouse model of chronic myelogenous leukemia (CML) conferred a growth advantage to leukemia stem cells (LSCs) over normal stem cells (97).